Related Experiment Video

Updated: Jun 24, 2026

Transmitochondrial Cybrid Generation Using Cancer Cell Lines
07:49

Transmitochondrial Cybrid Generation Using Cancer Cell Lines

Published on: March 17, 2023

Hybrids of aneuploid human cancer cells permit complementation of simple and complex cancer defects

David A Dezentje1, Dan E Arking, Madeleine S Q Kortenhorst

  • 1Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Cancer Biology & Therapy
|March 24, 2009
PubMed

Insights

Researchers created stable cancer cell hybrids to study complex cancer phenotypes. These hybrids helped identify genetic causes for altered drug responses and mitotic defects, offering new tools for cancer research.

Area of Science:

  • Cancer Biology
  • Genetics
  • Cell Biology

Background:

  • Complex cancer phenotypes, including altered differentiation, invasion, and metastasis, have unknown causes, likely involving multiple genes.
  • Simple cancer phenotypes, often due to single gene mutations affecting DNA repair or enzymatic pathways, are studied using genetic complementation.
  • Cell fusion is occasionally used for complex phenotypes, but hybrids from common aneuploid lines with chromosomal instability (CIN) are rare.

Purpose of the Study:

  • To create and characterize stable hybrids from two chromosomal instability (CIN) cancer cell lines.
  • To investigate the genetic basis of both simple and complex cancer phenotypes using these novel hybrid cell lines.
  • To develop new tools for positional cloning and classification of cancer phenotypes.

Main Methods:

  • Generation of stable hybrid cell lines by fusing two aneuploid CIN cell lines.
  • Assessment of complementation for a Fanconi anemia pathway defect and restoration of drug resistance.
  • Evaluation of mitotic spindle checkpoint function in hybrid clones.
  • SNP chip analysis (Affymetrix 100K) to map chromosomal loci differences among hybrid clones.

Main Results:

  • Stable hybrids with a near-complete genetic sum of parental karyotypes were successfully created.
  • Complementation of the Fanconi anemia pathway defect was observed in all hybrids, restoring normal drug resistance.
  • Partial correction of the defective mitotic spindle checkpoint in some hybrids suggested a multigenic origin for this defect.
  • Chromosomal loci differences were mapped among phenotypically distinct hybrid clones.

Conclusions:

  • Fused CIN cell lines provide a powerful platform for studying cancer genetics.
  • This approach facilitates the positional cloning and classification of genes underlying complex cancer phenotypes.
  • Mapped hybrids offer new avenues for understanding drug responses and mechanical defects in cancer.

More Related Videos

Generation and Isolation of Cell Cycle-arrested Cells with Complex Karyotypes05:22

Generation and Isolation of Cell Cycle-arrested Cells with Complex Karyotypes

Published on: April 13, 2018

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells12:04

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells

Published on: March 10, 2023

Related Concept Videos

Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Complementation Tests00:49

Complementation Tests

A complementation test is a simple cross to identify whether the two mutations are located on the same gene or different genes. It was first performed by Edward Lewis in the 1940s while working on fruit flies. He developed the test to identify the location and arrangement of different mutations on chromosomes.
Organisms heterozygous for different mutations are crossed pairwise in all combinations. If present on different genes, the mutations can complement each other by providing the missing...